Using chart review to screen for medication errors and adverse drug events

2002 ◽  
Vol 59 (23) ◽  
pp. 2323-2325 ◽  
Author(s):  
Rainu Kaushal
Keyword(s):  
Medication Errors ◽  
Chart Review ◽  
Adverse Drug Events

scholarly journals Prevalence of Medication Errors in Admitted Patients at the Philippine General Hospital

2017 ◽  
Vol 51 (2) ◽  
Author(s):  
Paul Matthew D. Pasco ◽  
Ruzanne M. Caro ◽  
Connie L. Cruz ◽  
Nerissa M. Dando ◽  
Iris Thiele C. Isip-Tan ◽  
...  
Keyword(s):  
Medication Errors ◽  
Chart Review ◽  
Prospective Observational Study ◽  
Adverse Drug Events ◽  
Medical Center ◽  
Inappropriate Drug ◽  
Systematic Sampling ◽  
First Year ◽  
True Prevalence ◽  
Review Study

Background. Medication errors are preventable events that can cause or lead to inappropriate drug use. Knowing the prevalence and types of errors can help us institute corrective measures and avoid adverse drug events. Objective. This study determined the prevalence of medication errors and its specific types in the four main service wards of a tertiary government training medical center. Methods. This is a retrospective, descriptive chart review study. From the master list of admissions, systematic sampling was done to retrieve the required number of charts. Relevant pages such as order sheets, nurses’ notes, therapeutic sheets were photographed. For prolonged admissions, only the first 7 days were reviewed. Each chart was evaluated by two people who then met and agreed on the errors identified. Results. The overall prevalence of medication errors is 97.8%. Pediatrics had the most (63.3/chart), followed by Medicine, OBGynecology, and Surgery (7.3/chart). The most common type of errors identified were prescribing, followed by compliance, then administration errors. Conclusion. Medication errors are present in the four main wards in our hospital. We recommend orientation of all incoming first year residents on proper ordering and prescribing of drugs, as well as a prospective observational study to determine true prevalence of all types of medication errors.

scholarly journals Surveillance of Adverse Drug Events Associated with Tocilizumab in Hospitalized Veterans with COVID-19 to Inform Patient Safety and Pandemic Preparedness

2021 ◽  
pp. 1-12
Author(s):  
Rupak Datta ◽  
Alexis Barrett ◽  
Muriel Burk ◽  
Cedric Salone ◽  
Anthony Au ◽  
...  
Keyword(s):  
Patient Safety ◽  
Median Time ◽  
Concomitant Medication ◽  
Chart Review ◽  
Adverse Drug Events ◽  
National Sample ◽  
Pandemic Preparedness ◽  
Medication Discontinuation

Abstract We evaluated adverse drug events (ADE) by chart review in a random national sample of 428 Veterans with COVID-19 who received tocilizumab (n=173/428). ADEs (median time=5 days) occurred in 51/173 (29%) and included hepatoxicity (n=29) and infection (n=13). Concomitant medication discontinuation occurred in 22% of ADE patients; mortality was 39%.

scholarly journals Reducing the Risk of Harm from Medication Errors in Children

2013 ◽  
Vol 6 ◽  
pp. HSI.S10454 ◽  
Author(s):  
Daniel R. Neuspiel ◽  
Melissa M. Taylor
Keyword(s):  
Medication Errors ◽  
Health Care Providers ◽  
Adverse Drug Events ◽  
Chronic Illnesses ◽  
Future Research ◽  
Care Providers ◽  
Pediatric Age Group ◽  
Improvement Interventions ◽  
Communication Ability ◽  
Quality Improvement Interventions

Medication errors affect the pediatric age group in all settings: outpatient, inpatient, emergency department, and at home. Children may be at special risk due to size and physiologic variability, limited communication ability, and treatment by nonpediatric health care providers. Those with chronic illnesses and on multiple medications may be at higher risk of experiencing adverse drug events. Some strategies that have been employed to reduce harm from pediatric medication errors include e-prescribing and computerized provider order entry with decision support, medication reconciliation, barcode systems, clinical pharmacists in medical settings, medical staff training, package changes to reduce look-alike/sound-alike confusion, standardization of labeling and measurement devices for home administration, and quality improvement interventions to promote nonpunitive reporting of medication errors coupled with changes in systems and cultures. Future research is needed to measure the effectiveness of these preventive strategies.

Improving Medication Safety Through the Use of Metrics

2013 ◽  
Vol 27 (1) ◽  
pp. 61-64
Author(s):  
Robert D. Beckett ◽  
Marina Yazdi ◽  
Laura J. Hanson ◽  
Ross W. Thompson
Keyword(s):  
Medication Errors ◽  
Medication Safety ◽  
Adverse Drug Events ◽  
Safety Information ◽  
Medication Use ◽  
Cross Sectional Study ◽  
Survey Instrument ◽  
Sectional Study ◽  
Cross Sectional ◽  
Safety Metrics

Purpose: Describe medication safety metrics used at University HealthSystem Consortium (UHC) institutions and recommend a meaningful way to report and communicate medication safety information across an organization. Methods: A cross-sectional study was conducted using an electronically distributed, open-ended survey instrument. Results: Twenty percent of the UHC institutions responded to our survey. Seventy-seven percent of those institutions responding to our survey reported their organization has defined metrics to measure medication safety; an additional 21% of the institutions were still in the process of defining metrics. Of metrics that were reported, 33% were true medication safety metrics. Results are distributed to a wide variety of institutional venues. Conclusion: Institutions should take several actions related to medication safety including defining local metrics; building metrics addressing preventable adverse drug events, medication errors, and technology; and reporting results to a variety of venues in order to design specific interventions to improve local medication use.

scholarly journals Medication Safety: Reducing Anesthesia Medication Errors and Adverse Drug Events in Dentistry Part 2

2020 ◽  
Vol 67 (1) ◽  
pp. 48-59
Author(s):  
Daniel S. Sarasin ◽  
Jason W. Brady ◽  
Roy L. Stevens
Keyword(s):  
General Anesthesia ◽  
Medication Errors ◽  
Medication Safety ◽  
Adverse Drug Events ◽  
Contributing Factors ◽  
Full Spectrum ◽  
Dental Profession ◽  
Novel Method ◽  
Dental Providers ◽  
Preventive Methods

For decades, the dental profession has provided the full spectrum of anesthesia services ranging from local anesthesia to general anesthesia in the office-based ambulatory environment to alleviate pain and anxiety. However, despite a reported record of safety, complications occasionally occur. Two common contributing factors to general anesthesia and sedation complications are medication errors and adverse drug events. The prevention and early detection of these complications should be of paramount importance to all dental providers who administer or otherwise use anesthesia services. Unfortunately, there is a lack of literature currently available regarding medication errors and adverse drug events involving anesthesia for dentistry. As a result, the profession is forced to look to the medical literature regarding these issues not only to assess the likely severity of the problem but also to develop preventive methods specific for general anesthesia and sedation as practiced within dentistry. Part 1 of this 2-part article illuminated the problems of medication errors and adverse drug events, primarily as documented within medicine. Part 2 will focus on how these complications affect dentistry, discuss several of the methods that medical anesthesia has implemented to manage such problems that may have utility in dentistry, and introduce a novel method for addressing these issues within dentistry known as the Dental Anesthesia Medication Safety Paradigm (DAMSP).

Medication errors and adverse drug events in an intensive care unit: Direct observation approach for detection

2006 ◽  
Vol 34 (2) ◽  
pp. 415-425 ◽  
Author(s):  
Brian J. Kopp ◽  
Brian L. Erstad ◽  
Michelle E. Allen ◽  
Andreas A. Theodorou ◽  
Gail Priestley
Keyword(s):  
Intensive Care Unit ◽  
Intensive Care ◽  
Medication Errors ◽  
Direct Observation ◽  
Adverse Drug Events

Detection of potential look-alike/sound-alike medication errors using Veterans Affairs administrative databases

2018 ◽  
Vol 75 (19) ◽  
pp. 1460-1466 ◽  
Author(s):  
Jessica M. Zacher ◽  
Francesca E. Cunningham ◽  
Xinhua Zhao ◽  
Muriel L. Burk ◽  
Von R. Moore ◽  
...  
Keyword(s):  
Medication Errors ◽  
Chart Review ◽  
Veterans Affairs ◽  
Error Rates ◽  
High Rate ◽  
Administrative Databases ◽  
Potential Error ◽  
Actual Error ◽  
History Of ◽  
History Of Use

Abstract Purpose Results of a study to estimate the prevalence of look-alike/sound-alike (LASA) medication errors through analysis of Veterans Affairs (VA) administrative data are reported. Methods Veterans with at least 2 filled prescriptions for 1 medication in 20 LASA drug pairs during the period April 2014–March 2015 and no history of use of both medications in the preceding 6 months were identified. First occurrences of potential LASA errors were identified by analyzing dispensing patterns and documented diagnoses. For 7 LASA drug pairs, potential errors were evaluated via chart review to determine if an actual error occurred. Results Among LASA drug pairs with overlapping indications, the pairs associated with the highest potential-error rates, by percentage of treated patients, were tamsulosin and terazosin (3.05%), glipizide and glyburide (2.91%), extended- and sustained-release formulations of bupropion (1.53%), and metoprolol tartrate and metoprolol succinate (1.48%). Among pairs with distinct indications, the pairs associated with the highest potential-error rates were tramadol and trazodone (2.20%) and bupropion and buspirone (1.31%). For LASA drug pairs found to be associated with actual errors, the estimated error rates were as follows: lamivudine and lamotrigine, 0.003% (95% confidence interval [CI], 0–0.01%); carbamazepine and oxcarbazepine, 0.03% (95% CI, 0–0.09%); and morphine and hydromorphone, 0.02% (95% CI, 0–0.05%). Conclusion Through the use of administrative databases, potential LASA errors that could be reviewed for an actual error via chart review were identified. While a high rate of potential LASA errors was detected, the number of actual errors identified was low.

Differences in adverse drug events and medication errors among pediatric inpatients aged <3 and ≥3 years: The JADE study

2021 ◽  
pp. 251604352110467
Author(s):  
Jiro Takeuchi ◽  
Mio Sakuma ◽  
Yoshinori Ohta ◽  
Hiroyuki Ida ◽  
Takeshi Morimoto
Keyword(s):  
Hospital Stay ◽  
Medication Errors ◽  
Primary Outcome ◽  
Pediatric Patients ◽  
Adverse Drug Events ◽  
Medication Use ◽  
Skill Levels ◽  
Linguistic Skills ◽  
Events Study

Background Adverse drug events (ADEs) are defined as any injuries due to medication use. We hypothesized that the incidences of ADEs and medication errors (MEs) could be associated with linguistic skills of pediatric patients. Methods We analyzed data from the Japan Adverse Drug Events study on pediatric inpatients. This study included inpatients aged one months and older and less than seven years old. We compared the primary outcome of ADEs and MEs between patients aged under three years and three years and older as children typically do not acquire sufficient linguistic skills until around three years of age. Results This study included 639 patients; 412 (64%) patients aged under three years and 227 (36%) patients aged three years and older. We identified 241 ADEs in 639 patients; 152 ADEs among patients aged under three years (37 ADEs per 100 patients) and 89 ADEs among those aged three years and older (39 ADEs per 100 patients). ADEs among patients aged under three years were less likely to be found (49 ADEs) during their hospital stay than those aged three years and older (20 ADEs) ( P = 0.02). Among 172 MEs identified in 639 patients, 25 MEs (15%) resulted in ADEs; 23 (92%) occurred to those aged under three years and two (8%) occurred to those aged three years and older ( P = 0.0008). Conclusion ADEs were less likely to be found and MEs resulted in ADEs more frequently in patients under three years old, and these differences could be explained by differences in their linguistic skill levels.

Sign in / Sign up

Export Citation Format

Share Document